Answers are grounded in this paper and cite their sources.
Background. Calcitonin receptor-like receptor (CALCRL) binds no ligand on its own: it must be partnered by a receptor activity-modifying protein (RAMP), and RAMP1, RAMP2 or RAMP3 turns it into the CGRP, AM1 or AM2 receptor. Receptor identity is therefore set not by how much CALCRL a neuron has but by how it divides that pool. Every approved CGRP-pathway drug targets this receptor or its ligand. Whether sensory neurons divide the pool the same way in humans and mice has not been measured. Methods. We re-analysed public single-cell and single-nucleus RNA sequencing of human, macaque, mouse and rat trigeminal and dorsal root ganglia, anchored by a three-species series from one laboratory and one pipeline. The primary statistic compares two RAMPs within the same cell (paired exact McNemar), which cancels sequencing depth, capture efficiency and ambient RNA by construction. Detection floors, depth bins, preparation strata and an annotation-space audit were fixed before the data were read. Results. In a depth-matched gate, mouse neurons allocate the pool to RAMP2 (within-cell odds ratio 25.15 for RAMP2 over RAMP3) and macaque neurons give it to RAMP3 (0.105), a 239-fold species × RAMP interaction (z = − 67.3) that survives every preparation stratum and recurs in three further macaque datasets from one study. Human neurons follow RAMP3 in every dataset available, including all nine of a 53,596-neuron reference atlas, where the paired odds ratio falls below parity everywhere and pools to 0.114 (95% CI 0.059–0.220, I² = 98.8%); the direction is unambiguous but the magnitude is not, so we report a pooled interval rather than a single number. The difference is a family-internal crossover, holds across cell types, and extends to satellite glia, where mouse allocates to RAMP2 (odds ratio 0.0019) while RAMP2 never exceeds 3.84% detection in any human glial gate. Conclusions. The RAMP that partners CALCRL in sensory neurons is a species variable, graded across species with one qualitative step. Rodent pharmacology of "the sensory-neuron CGRP receptor" therefore reads it against a differently composed pool: AM1-dominated in mouse, AM2-dominated in primate neurons.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: